Navigation Links
Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool
Date:11/4/2009

Real-time in situ FTIR analysis has become a standard tool in the chemical and pharmaceutical industries for providing information rich data that allows a more thorough understanding of reactions during the development and scale-up of chemical processes. METTLER TOLEDO is offering a free webinar discussing the Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool on November 11, 2009.

Columbia, MD (PRWEB) November 4, 2009 -- METTLER TOLEDO recently announced that it will host a free webinar Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool on November 11, 2009. Real-time in situ FTIR analysis has become a standard tool in the chemical and pharmaceutical industries for providing information rich data that allows a more thorough understanding of reactions during the development and scale-up of chemical processes.

This webinar will use several case studies from recent literature to illustrate how real-time mid-infrared data was used to provide valuable information that resulted in more efficient chemical development. The case studies include:

 
  • Conversion of a batch process to continuous flow process
  • Role of Process Analytical Technologies (PAT) in defining a manufacturing process of an Active Pharmaceutical Ingredient (API)
  • In situ data provides critical information about the source of process variability
This webinar will be helpful to Chemists and Chemical Engineers working in batch processing, continuous processing, or continuous chemistry in the Pharmaceutical and Chemical industries.

###

Read the full story at http://www.prweb.com/releases/chemical/processes/prweb3149614.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Laureate Pharma Welcomes Three New Members to Business Development Team
2. BioWa and NKTT Announce Licensing of BioWas POTELLIGENT(R) Technology For Use in Antibody Research and Development
3. Monsanto and Huazhong Agricultural University Enter Into Collaboration Focusing on Development of Plant Biotechnology
4. GreenHouse and Allard Research and Development Partner to Revolutionize Large-Scale Ethanol Fuel Systems
5. Jeremy M. Stipkala to Lead Symposium Entitled Patent Law Developments at SERMACS 2009
6. goBalto Introduces Web-based Solution to Manage Drug-development Collaborations
7. 17th International Process Development Conference to Feature Presentations on Safety, Process Development, Crystallization, PAT, Scale-Up and Production
8. Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist
9. Calibration Free Supersaturation Assessment and Control for the Development and Optimization of Crystallization Processes
10. Cryo-Cell Internationals Stem Cell Research and Development Helps the Fight Against Breast Cancer
11. YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool 
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, the leading ... today announced that it has been named to The Silicon Review’s “20 Fastest Growing ... other markets, Cambridge Semantics serves the needs of end users facing some of the ...
(Date:4/27/2016)... SPRING, Md. and RESEARCH TRIANGLE ... Therapeutics Corporation (NASDAQ: UTHR ) announced today ... Executive Officer, of United Therapeutics will provide an overview ... Bank 41 st Annual Health Care Conference. ... 5, 2016, at 10:00 a.m. Eastern Time, and can ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan Ross, Ph.D. ... Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology from the ... the suppression of graft vs. host disease (GVHD) under UM Professor Robert Levy Ph.D. ...
(Date:4/26/2016)... ... April 26, 2016 , ... BaseHealth , the ... the company as Chief Business Officer. Arianpour, a genomics pioneer and visionary commercial ... was most recently Chief Commercial Officer of Pathway Genomics. He has held senior ...
Breaking Biology Technology:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):